Molecular Partners
MOLN
8 hedge funds and large institutions have $3.83M invested in Molecular Partners in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.03% less ownership
Funds ownership: 2.63% → 2.6% (-0.03%)
2% less capital invested
Capital invested by funds: $3.91M → $3.83M (-$77.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.61K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$50.2K |
| 2 |
JP Morgan Chase
New York
|
-$4 |
MOLN Hedge Fund Activity: Q1 2024 in Review
8 of the 6,957 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q1 2024, worth a combined $3.83M — down 2% from $3.91M a quarter earlier.
Fund positioning in MOLN was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $6.61K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $50.2K sold.
- 8 institutional investors held Molecular Partners (MOLN) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $3.83M of Molecular Partners stock for Q1 2024, down 2% quarter-over-quarter.
- 2 funds opened new Molecular Partners positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest Molecular Partners buyer in Q1 2024 was Royal Bank of Canada, an estimated $6.61K added.
- The largest Molecular Partners seller in Q1 2024 was Susquehanna International Group, an estimated $50.2K sold.
Based on aggregated 13F filings for Q1 2024.